- Correspondence as Topic1
- Disclosure1
- Drug Development -- methods1
- Drug Development -- standards1
- Drug Evaluation1
- Drug Evaluation, Preclinical1
- Electronic Data Processing1
- Endpoint Determination1
- Facility Regulation and Control1
- Hematologic Neoplasms -- drug therapy1
- Humans1
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy1
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy1
- Leukemia, Myeloid, Acute -- drug therapy1
- Leukemia, Promyelocytic, Acute -- drug therapy1
- Licensure1
- Multiple Myeloma -- drug therapy1
- Neoplasm, Residual1
- Patient Selection1
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy1